Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Catalina Barceló"'
Autor:
Adama Gansane, Moussa Lingani, Adoke Yeka, Alain Nahum, Marielle Bouyou-Akotet, Ghyslain Mombo-Ngoma, Grace Kaguthi, Catalina Barceló, Bart Laurijssens, Cathy Cantalloube, Fiona Macintyre, Elhadj Djeriou, Andreas Jessel, Raphaël Bejuit, Helen Demarest, Anne Claire Marrast, Siaka Debe, Halidou Tinto, Afizi Kibuuka, Diolinda Nahum, Denise Patricia Mawili-Mboumba, Rella Zoleko-Manego, Irene Mugenya, Frederick Olewe, Stephan Duparc, Bernhards Ogutu
Publikováno v:
Malaria Journal, Vol 22, Iss 1, Pp 1-16 (2023)
Abstract Background The contribution of artefenomel to the clinical and parasiticidal activity of ferroquine and artefenomel in combination in uncomplicated Plasmodium falciparum malaria was investigated. Methods This Phase 2a, randomized, open-label
Externí odkaz:
https://doaj.org/article/f65785a4b7b84297a418e877222c7d6a
Autor:
Roger Kouyos, Philip TARR, Sabine Yerly, Perrine Courlet, Monia Guidi, Chantal Csajka, Catalina Barceló Campomar, Matthias Cavassini, Laurent Decosterd, Huldrych Günthard, Dominique Laurent Braun, Andri Rauch, Thierry Buclin
Publikováno v:
Journal of Antimicrobial Chemotherapy. 74:2690-2697
Objectives Dolutegravir is widely prescribed owing to its potent antiviral activity, high genetic barrier and good tolerability. The aim of this study was to characterize dolutegravir’s pharmacokinetic profile and variability in a real-life setting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5f018e875ca10d1fb4202a36774b563
https://doi.org/10.1093/jac/dkz217
https://doi.org/10.1093/jac/dkz217
Autor:
Enos Bernasconi, Hansjakob Furrer, Sebastian Haubitz, Chantal Csajka, Christian Hammer, Monia Guidi, Barbara Hasse, Philip E. Tarr, Aziz Chaouch, Matthias Cavassini, Alexandra Calmy, Jacques Fellay, Thierry Buclin, Christian W. Thorball, Catalina Barceló, Alexandra U. Scherrer
Publikováno v:
Open forum infectious diseases, vol. 7, no. 1, pp. ofz464
Barceló, Catalina; Guidi, Monia; Thorball, Christian W; Hammer, Christian; Chaouch, Aziz; Scherrer, Alexandra U; Hasse, Barbara; Cavassini, Matthias; Furrer, Hansjakob; Calmy, Alexandra; Haubitz, Sebastian; Bernasconi, Enos; Buclin, Thierry; Fellay, Jacques; Tarr, Philip E; Csajka, Chantal (2020). Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral Therapy. Open Forum Infectious Diseases, 7(1), ofz464. Oxford University Press 10.1093/ofid/ofz464
Open Forum Infectious Diseases
Open Forum Infectious Diseases, Vol. 7, No 1 (2020) P. ofz464
Barceló, Catalina; Guidi, Monia; Thorball, Christian W; Hammer, Christian; Chaouch, Aziz; Scherrer, Alexandra U; Hasse, Barbara; Cavassini, Matthias; Furrer, Hansjakob; Calmy, Alexandra; Haubitz, Sebastian; Bernasconi, Enos; Buclin, Thierry; Fellay, Jacques; Tarr, Philip E; Csajka, Chantal (2020). Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral Therapy. Open Forum Infectious Diseases, 7(1), ofz464. Oxford University Press 10.1093/ofid/ofz464
Open Forum Infectious Diseases
Open Forum Infectious Diseases, Vol. 7, No 1 (2020) P. ofz464
Objective. There is limited data on abdominal obesity and the influence of genetics on weight change after ant iretroviral therapy (ART) initiation. We assessed body mass index (BMI) and waist hip ration (WHR) change over time in the Swiss HIV Cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eee1ebe7269ea5c9c054fa96f046343
https://doi.org/10.1093/ofid/ofz464
https://doi.org/10.1093/ofid/ofz464
Autor:
Ana Steffen, Léna Dietrich, Catalina Barceló, Matthias Cavassini, Barbara Hasse, Sophie de Seigneux, Lene Ryom, C. Csajka, Philip E. Tarr, Christian W. Thorball, Enos Bernasconi, Jacques Fellay, Maja Weisser, Bruno Ledergerber, Hansjakob Furrer, Felix Burkhalter
Publikováno v:
Clinical Infectious Diseases, Vol. 70, No 5 (2020) pp. 890-897
BackgroundIn human immunodeficiency virus (HIV), the relative contribution of genetic background, clinical risk factors, and antiretrovirals to chronic kidney disease (CKD) is unknown.MethodsWe applied a case-control design and performed genome-wide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb8a71094efff01add32711865758057
https://doi.org/10.1093/cid/ciz280
https://doi.org/10.1093/cid/ciz280
Autor:
Catalina Barceló, Margalida Rotger, Enos Bernasconi, Istvan Bartha, Helen Kovari, Bruno Ledergerber, Patrick Schmid, Rainer Weber, Thomas Junier, Claudia Brun del Re, Christoph A Fux, Jacques Fellay, Philip E. Tarr, Emmanuel Biver
Publikováno v:
Junier, Thomas; Rotger, Margalida; Biver, Emmanuel; Ledergerber, Bruno; Barceló, Catalina; Bartha, Istvan; Kovari, Helen; Schmid, Patrick; Fux, Christoph; Bernasconi, Enos; Brun del Re, Claudia; Weber, Rainer; Fellay, Jacques; Tarr, Philip E (2016). Contribution of Genetic Background and Clinical Risk Factors to Low-Trauma Fractures in Human Immunodeficiency Virus (HIV)-Positive Persons: The Swiss HIV Cohort Study. Open Forum Infectious Diseases, 3(2), ofw101. Oxford University Press 10.1093/ofid/ofw101
Europe PubMed Central
Open Forum Infectious Diseases, vol. 3, no. 2, pp. ofw101
Open Forum Infectious Diseases
Open Forum Infectious Diseases, Vol. 3, No 2 / Art: ofw101 (2016)
Europe PubMed Central
Open Forum Infectious Diseases, vol. 3, no. 2, pp. ofw101
Open Forum Infectious Diseases
Open Forum Infectious Diseases, Vol. 3, No 2 / Art: ofw101 (2016)
Background. The impact of human genetic background on low-trauma fracture (LTF) risk has not been evaluated in the context of human immunodeficiency virus (HIV) and clinical LTF risk factors. Methods. In the general population, 6 common single-nucleo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e35565a51a157cbc58b7c4949302f5a
https://boris.unibe.ch/84565/1/ofw101.pdf
https://boris.unibe.ch/84565/1/ofw101.pdf
Autor:
Catalina, Barceló, Frédéric, Gaspar, Manel, Aouri, Alice, Panchaud, Margalida, Rotger, Monia, Guidi, Matthias, Cavassini, Thierry, Buclin, Laurent A, Decosterd, Chantal, Csajka, S, Yerly
Publikováno v:
The Journal of antimicrobial chemotherapy. 71(7)
OBJECTIVES Co-formulated elvitegravir, cobicistat, tenofovir disoproxil fumarate and emtricitabine is among the preferred regimens for first-line ART. A population approach was used to characterize the pharmacokinetics of elvitegravir and cobicistat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b152f6a5dbb647cc8dd84c055c43d635
https://pubmed.ncbi.nlm.nih.gov/27029846
https://pubmed.ncbi.nlm.nih.gov/27029846
Autor:
MAIMÓ, CATALINA BARCELÓ
Publikováno v:
Make Modern; Sep/Oct2020, Issue 36, p36-40, 5p, 7 Color Photographs
Autor:
Laura E. de Vries, Patrick A. M. Jansen, Catalina Barcelo, Justin Munro, Julie M. J. Verhoef, Charisse Flerida A. Pasaje, Kelly Rubiano, Josefine Striepen, Nada Abla, Luuk Berning, Judith M. Bolscher, Claudia Demarta-Gatsi, Rob W. M. Henderson, Tonnie Huijs, Karin M. J. Koolen, Patrick K. Tumwebaze, Tomas Yeo, Anna C. C. Aguiar, Iñigo Angulo-Barturen, Alisje Churchyard, Jake Baum, Benigno Crespo Fernández, Aline Fuchs, Francisco-Javier Gamo, Rafael V. C. Guido, María Belén Jiménez-Diaz, Dhelio B. Pereira, Rosemary Rochford, Camille Roesch, Laura M. Sanz, Graham Trevitt, Benoit Witkowski, Sergio Wittlin, Roland A. Cooper, Philip J. Rosenthal, Robert W. Sauerwein, Joost Schalkwijk, Pedro H. H. Hermkens, Roger V. Bonnert, Brice Campo, David A. Fidock, Manuel Llinás, Jacquin C. Niles, Taco W. A. Kooij, Koen J. Dechering
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-16 (2022)
Here, de Vries et al. perform a pre-clinical characterization of the antimalarial compound MMV693183: the compound targets acetyl-CoA synthetase, has efficacy in humanized mice against Plasmodium falciparum infection, blocks transmission to mosquito
Externí odkaz:
https://doaj.org/article/5a569da9aa694e86aa5e04aa0c21ba75
Publikováno v:
International Urology and Nephrology. 34:447-451
The aim of this paper is to study possible synergic effects between crystallization-inhibitor molecules of low molecular weight on the hydroxyapatite and brushite crystal nucleation. Kinetic-turbidimetric measurements were performed to follow the nuc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::232d6d9073732fb913d175ea5c2035c3
https://doi.org/10.1023/a:1025671019653
https://doi.org/10.1023/a:1025671019653
Publikováno v:
International urology and nephrology. 34(4)
The aim of this paper is to study possible synergic effects between crystallization-inhibitor molecules of low molecular weight on the hydroxyapatite and brushite crystal nucleation. Kinetic-turbidimetric measurements were performed to follow the nuc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ada39b3fdb1d42a011bb11b1bdcc6813
https://pubmed.ncbi.nlm.nih.gov/14577482
https://pubmed.ncbi.nlm.nih.gov/14577482